Search Results

Agricola

Record details

Immunological effects of a novel RNA-based adjuvant in liver cancer patients.

• Authors : Circelli L; Exper. Immunotherapy Lab., Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, 'Fondazione Pascale' - Istituto di Ricovero e Cura a Caratteres Scientifico (IRCCS), Naples, Italy.; Petrizzo A

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*administration & dosage ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*immunology

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2017 Jan; Vol. 66 (1), pp. Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Research on Liver Cancer Reported by Researchers at First Affiliated Hospital of Nanchang University (Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients: A case report and literature review)

• Source: Immunotherapy Weekly. January 25, 2023, 5132

Record details

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB.

• Authors : Shike Lou; Zhujun Cao; Wanqing Chi

Subjects: IMMUNE checkpoint inhibitors; LIVER cancer; DRUG side effects

• Source: Frontiers in Pharmacology; 2023, p1-10, 10p

Record details

Research Data from Wujin Hospital Affiliated with Jiangsu University Update Understanding of Liver Cancer (A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients)

• Source: Immunotherapy Weekly. November 16, 2022, 4459

Record details

Study uncovers biomarkers that predict response and side effects from immunotherapy for liver cancer patients

• Source: NewsRx Health. June 5, 2022, p384

Record details

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at high-risk of recurrence.

• Source: Immunotherapy Weekly; 11/07/2023, p253-253, 1p

Record details

City of Hope first in US to offer this experimental drug for liver cancer patients

• Source: NewsRx Health & Science. August 25, 2019, p62

Record details

Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients.

• Source: PR Newswire. 2012.

Record details

Regulatory T cells in liver cancer patients may hinder cancer immunotherapy.

• Source: World Disease Weekly. 2005, pages. 1264

Record details